Abstract:Muscle-eye-brain (MEB) disease is a congenital muscular dystrophy (CMD) phenotype characterized by hypotonia at birth, brain structural abnormalities and ocular malformations. To date, few MEB cases have been reported in China where clinical recognition and genetic confirmatory testing on a research basis are recent developments. Here, we report the clinical and molecular genetics of three MEB disease patients. The patients had different degrees of muscle, eye and brain symptoms, ranging from congenital hypotonia, early-onset severe myopia and mental retardation to mild weakness, independent walking and language problems. This confirmed the expanding phenotypic spectrum of MEB disease with varying degrees of hypotonia, myopia and cognitive impairment. Brain magnetic resonance imaging showed cerebellar cysts, hypoplasia and characteristic brainstem flattening and kinking. Four candidate genes (POMGnT1, FKRP, FKTN and POMT2) were screened, and six POMGnT1 mutations (four novel) were identified, including five missense and one splice site mutation. Pathogenicity of the two novel variants in one patient was confirmed by POMGnT1 enzyme activity assay, protein expression and subcellular localization of mutant POMGnT1 in HeLa cells. Transfected cells harboring this patient’s L440R mutant POMGnT1 showed POMGnT1 mislocalization to both the Golgi apparatus and endoplasmic reticulum. We have provided clinical, histological, enzymatic and genetic evidence of POMGnT1 involvement in three unrelated MEB disease patients in China. The identification of novel POMGnT1 mutations and an expanded phenotypic spectrum contributes to an improved understanding of POMGnT1 structure–function relationships, CMD pathophysiology and genotype–phenotype correlations, while underscoring the need to consider POMGnT1 in Chinese MEB disease patients.

Novel Copy Number Variation of POMGNT1 Associated with Muscle-Eye-brain Disease Detected by Next-Generation Sequencing

Uniparental disomy for chromosome 1 with POMGNT1 splice-site variant causes muscle-eye-brain disease

Novel POMGnT1 Mutations Cause Muscle-Eye-brain Disease in Chinese Patients

Genetic Identification of Pathogenic Variations of the DMD Gene: a Retrospective Study from 10,481 Neonatal Patients Based on Next-Generation Sequencing Data

[Clinical and Mutation Analysis of a Chinese Family with Muscle Eye Brain Disease].

Phenotype and Genotype Study of Chinese POMT2-Related α-Dystroglycanopathy

A Gcg Expansion (gcg)(11) in Polyadenylate-Binding Protein Nuclear 1 Gene Caused Oculopharyngeal Muscular Dystrophy in A Chinese Family

Just Expect It: Compound Heterozygous Variants of POMT1 in a Consanguineous Family—The Role of Next Generation Sequencing in Neuromuscular Disorders

Clinical Exome Sequencing Identifies Novel Compound Heterozygous Mutations of the POMT2 Gene in Patients with Limb‐girdle Muscular Dystrophy

Novel mutations in B3GALNT2 gene causing α-dystroglycanopathy in Chinese patients

Non-coding CGG Repeat Expansion in LOC642361/NUTM2B-AS1 is Associated with a Phenotype of Oculopharyngodistal Myopathy.

Identification of compound heterozygous mutations in GNPTG in three siblings of a Chinese family with mucolipidosis type III gamma.

Gene Diagnosis of Oculopharyngeal Muscular Dystrophy in a Chinese Family by a Genescan Method

The GGC repeat expansion in NOTCH2NLC is associated with oculopharyngodistal myopathy type 3

Protein O-mannosyltransferase activities in lymphoblasts from patients with alpha-dystroglycanopathies

Novel and recurrent nuclear gene variations in a cohort of Chinese progressive external ophthalmoplegia patients with multiple mtDNA deletions

Novel SPEG variant cause centronuclear myopathy in China.

Homozygosity Mapping and Whole-Genome Sequencing Links a Missense Mutation in POMGNT1 to Autosomal Recessive Retinitis Pigmentosa.

Mutational spectrum of Chinese LGMD patients by targeted next-generation sequencing

CGG repeat expansion in LOC642361/NUTM2B-AS1 typically presents as oculopharyngodistal myopathy

CGG/CCG Repeat Expansions in LOC642361/NUTM2B-AS1 in Thai Patients With Oculopharyngodistal Myopathy